These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Efficacy of clopidrogel on reperfusion and high-sensitivity C-reactive protein in patients with acute myocardial infarction. Akbulut M; Kutlu M; Ozbay Y; Polat V; Bilen MN; Baydas A; Altas Y Mediators Inflamm; 2009; 2009():932515. PubMed ID: 19365587 [TBL] [Abstract][Full Text] [Related]
27. The role of clopidogrel in early and sustained arterial patency after fibrinolysis for ST-segment elevation myocardial infarction: the ECG CLARITY-TIMI 28 Study. Scirica BM; Sabatine MS; Morrow DA; Gibson CM; Murphy SA; Wiviott SD; Giugliano RP; McCabe CH; Cannon CP; Braunwald E J Am Coll Cardiol; 2006 Jul; 48(1):37-42. PubMed ID: 16814646 [TBL] [Abstract][Full Text] [Related]
28. Current antiplatelet therapy for Japanese patients with ST elevation acute myocardial infarction: J-AMI registry. Nakamura M; Yamagishi M; Ueno T; Hara K; Ishiwata S; Itoh T; Hamanaka I; Wakatsuki T; Sugano T; Kawai K; Kimura T Cardiovasc Interv Ther; 2013 Apr; 28(2):162-9. PubMed ID: 23233418 [TBL] [Abstract][Full Text] [Related]
29. Clinical impact of enhanced inhibition of P2Y12-mediated platelet aggregation in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. Capranzano P; Mehran R; Tamburino C; Stone GW; Dangas G Hosp Pract (1995); 2010 Nov; 38(4):38-43. PubMed ID: 21068525 [TBL] [Abstract][Full Text] [Related]
30. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study. Gibson CM; Murphy SA; Pride YB; Kirtane AJ; Aroesty JM; Stein EB; Ciaglo LN; Southard MC; Sabatine MS; Cannon CP; Braunwald E; Am Heart J; 2008 Jan; 155(1):133-9. PubMed ID: 18082504 [TBL] [Abstract][Full Text] [Related]
31. Clopidogrel is associated with better in-hospital and 30-day outcomes than ticlopidine after coronary stenting. L'Allier PL; Aronow HD; Cura FA; Bhatt DL; Albirini A; Schneider JP; Topol EJ; Ellis SG Can J Cardiol; 2003 Aug; 19(9):1041-6. PubMed ID: 12915931 [TBL] [Abstract][Full Text] [Related]
32. Temporary adjunctive cilostazol vs clopidogrel loading for ST-segment elevation acute myocardial infarction. Tanaka A; Ishii H; Sakakibara M; Okumura S; Jinno Y; Okada K; Suzuki S; Inoue Y; Murohara T Am J Cardiovasc Drugs; 2014 Apr; 14(2):131-6. PubMed ID: 24452598 [TBL] [Abstract][Full Text] [Related]
33. A comparative evaluation of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Dasbiswas A; Rao MS; Babu PR; Vijayvergiya R; Nayak R; Dani S; Tyagi S; Hiremath S; Patel T; Alexander T; Prakash VS; Singh DP; Yadav MK; Pathak K; Srivastava A J Assoc Physicians India; 2013 Feb; 61(2):114-6, 126. PubMed ID: 24471250 [TBL] [Abstract][Full Text] [Related]
34. Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial. Chin CT; Roe MT; Fox KA; Prabhakaran D; Marshall DA; Petitjean H; Lokhnygina Y; Brown E; Armstrong PW; White HD; Ohman EM; Am Heart J; 2010 Jul; 160(1):16-22.e1. PubMed ID: 20598967 [TBL] [Abstract][Full Text] [Related]
35. Increased reperfusion by glycoprotein IIb/IIIa receptor antagonist administration in case of unsuccessful and failed thrombolysis in patients with acute myocardial infarction: a pilot study. Di Pasquale P; Sarullo FM; Cannizzaro S; Vitrano MG; Giubilato A; Scalzo S; Giambanco F; Paterna S Ital Heart J; 2001 Oct; 2(10):751-6. PubMed ID: 11721719 [TBL] [Abstract][Full Text] [Related]